L23-20354-35337
2 vaccinations
4 coded responses
12 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 840 / UT
- Registered
- 2022-06-22
- Relationship
- Child or adolescent in my care
- Guardian
- 9UX-65786-56431
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-22
Registered in v-safe
-
2022-07-07
Dose 1 — Pfizer-BioNTech
-
2022-08-02
Survey response — day 21, dose 1, dependentMedDRA: Eczema, Pre-existing disease — Feeling: GoodFree text: Eczema flare ups.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-04
Dose 2 — Pfizer-BioNTech
- 2022-08-07
-
2022-08-08
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2022-08-09
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2022-08-10
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2022-08-11
Health check-in — day 7, dose 2, dependentFeeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2022-08-20
Survey response — day 14, dose 2, dependentMedDRA: Eczema nummular — Feeling: GoodFree text: Exzema type lesions since the first vaccine aren't improving.MedDRA releases: 2024-11 · check-in free text available
- 2022-08-26
-
2022-09-02
Survey response — day 28, dose 2, dependentMedDRA: Eczema, Pre-existing disease — Feeling: GoodFree text: Eczema keeps flaring up since the first vaccine. Doesn't seem to be improving.MedDRA releases: 2024-11 · check-in free text available
- 2022-09-08
-
2022-09-17
Survey response — day 42, dose 2, dependentMedDRA: Eczema — Feeling: GoodFree text: Eczema keeps returningMedDRA releases: 2024-11 · check-in free text available
- 2022-11-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-07 | Pfizer-BioNTech | No |
| 2 | 2022-08-04 | Pfizer-BioNTech | No |
Free text
Release 12 — day 21, dose 1, dependent
Symptoms: Eczema flare ups.
Release 12 — day 14, dose 2, dependent
Symptoms: Exzema type lesions since the first vaccine aren't improving.
Release 12 — day 28, dose 2, dependent
Symptoms: Eczema keeps flaring up since the first vaccine. Doesn't seem to be improving.
Release 12 — day 42, dose 2, dependent
Symptoms: Eczema keeps returning
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Eczema | · | · | ✓ |
| SD | Eczema nummular | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release